Showing results (161-170 of 5,042) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|July 22, 2015
Occupational stress and personality traits in multiple sclerosis: A preliminary studyChiara Concetta Incerti, Giuseppe Magistrale, Ornella Argento, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?Gavin Giovannoni, Benjamin Turner, Sharmilee Gnanapavan, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic reviewB Amatya, M P Galea, J Kesselring, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40 mg three-times weekly versus 20 mg daily in patients with relapsing-remitting multiple sclerosisJerry S Wolinsky, T Erik Borresen, Dennis W Dietrich, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy riskBhupendra O Khatri, Jeffery Garland, Joseph Berger, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Prognostic factors associated with long-term disability and secondary progression in patients with Multiple SclerosisClaudia Cristina Ferreira Vasconcelos, Juliana Calvet Kallenbach Aurenção, Luiz Claudio Santos Thuler, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosisAlberto Gajofatto
Multiple Sclerosis and Related Disorders|July 27, 2016
Anti-N-methyl-d-aspartate receptor encephalitis in a patient with neuromyelitis optica spectrum disordersJing-Jing Luo, He Lv, Wei Sun, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Adherence and persistence to drug therapies for multiple sclerosis: A population-based studyCharity Evans, Ruth Ann Marrie, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|July 27, 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trialsTobias Derfuss, Daniel Ontaneda, Jacqueline Nicholas, et al.
Pageof 505